Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma.

Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma.

Item
http://www.wikidata.org/entity/Q33383056
Current and emerging treatment options for patients with relapsed myelomaIncidence and risk of cardiotoxicity associated with bortezomib in the treatment of cancer: a systematic review and meta-analysisTreatment of multiple myeloma bone disease: experimental and clinical data.Good clinical activity and favorable toxicity profile of once weekly bortezomib, fotemustine, and dexamethasone (B-MuD) for the treatment of relapsed multiple myeloma.Modified bortezomib, adriamycin and dexamethasone (PAD) regimen in advanced multiple myeloma.The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumorsProteasome inhibition and its therapeutic potential in multiple myelomaEmerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma.The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.Multiple myeloma in the marrow: pathogenesis and treatments.How best to use new therapies in multiple myeloma.Evidence-based mini-review: treatment options for patients with relapsed/refractory myeloma previously treated with novel agents and high-dose chemotherapy and autologous stem-cell transplantation.Choosing treatment options for patients with relapsed/refractory multiple myeloma.Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
P2860

Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma.

Item
http://www.wikidata.org/entity/Q33383056
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Bortezomib, low-dose intraveno ...... ith relapsed multiple myeloma.
@ast
Bortezomib, low-dose intraveno ...... ith relapsed multiple myeloma.
@en
type
label
Bortezomib, low-dose intraveno ...... ith relapsed multiple myeloma.
@ast
Bortezomib, low-dose intraveno ...... ith relapsed multiple myeloma.
@en
prefLabel
Bortezomib, low-dose intraveno ...... ith relapsed multiple myeloma.
@ast
Bortezomib, low-dose intraveno ...... ith relapsed multiple myeloma.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Bortezomib, low-dose intraveno ...... ith relapsed multiple myeloma.
@en
P2093
P304
P31
P356
10.1111/J.1365-2141.2008.07572.X
P407
P433
P478
P50
P577
P5875
P698
P921